Source: Annual Congress 2001 - Pathophysiology of OSA
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Oliven, J. J. Allan, M. Bennett, P. L. Smith, A. R. Schwartz (Haifa, Israel; Baltimore, United States Of America). Upper airway (UAW) pressure-flow response to electrical stimulation (ES) of tongue protrusors (TP) and retractors (TR) in patients with obstructive sleep apnea (OSA). Eur Respir J 2001; 16: Suppl. 31, 2206

Member's Comments

No comment yet.

Related content which might interest you: Naso-(NP) and oro-pharyngeal (OP) cross-sectional area (CSA) and airflow response to genioglossus (GG) contraction in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2004 - Non-CPAP therapy for OSA Year: 2004 Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010 CPAP-induced changes in upper airway (UA) dynamics assessed with magnetic phrenic nerve stimulation in awake obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2001; 18: Suppl. 33, 331s Year: 2001 Failure of upper airway dilator muscle activation to restore pharyngeal patency in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2008 - Pathogenesis of obstructive sleep apnoea Year: 2008 Relationship between nerve tissue and inflammatory cell infiltration in the upper airway (UA) of obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004 Neural respiratory drive (NRD) during continuous positive airway pressure (CPAP) titration in awake obese subjects with obstructive sleep apnoea (OSA) Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing Year: 2015 Long-term effects of noninvasive mechanical ventilation (NMV) in COPD patients with obstructive sleep apnoea (OSA) (overlap syndrome) Source: Eur Respir J 2001; 18: Suppl. 33, 402s Year: 2001 Is impulse oscillometry (IOS) useful in detecting upper airway obstruction (UAO) in suspected obstructive sleep apnoea and hypopnoea syndrome (OSAHS)? Source: Annual Congress 2004 - Airway resistance: application and technique Year: 2004 Pharyngeal compliance (Cph) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 641s Year: 2006 Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS) Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 The effect of volume targeted pressure support (PS) ventilation with autotitrating expiratory positive airways pressure (EPAP) and back up rate (BUR) on sleep quality in COPD-obstructive sleep apnoea (OSA) overlap syndrome Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing? Year: 2013 Positional obstructive sleep apnea (OSA) and automatic positive airway pressure (APAP) therapy Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012 Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP) Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020 Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Study of inflammatory markers (C-reactive protein & tumor necrosis factor-α) in moderate to severe obstructive sleep apnea hypopnea syndrome (OSAHS) and their response to treatment with nasal continuous positive airway pressure (nCPAP) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020